[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337515-105":59,"doc-detail-337515-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","secondary-bladder-and-colorectal-cancer-after-treatments-for-prostate-cancer-a-population-based-study","Secondary bladder and colorectal cancer after treatments for prostate cancer - A population based study","","Study evaluates whether prostate cancer (PCa) treatments predispose patients to secondary malignancies in the bladder and colorectum. Background notes that radiotherapy may increase risk, and aims to quantify associations for radical prostatectomy (RP), external beam radiation therapy (EBRT), brachytherapy (BT), and androgen deprivation therapy (ADT). Using Quebec administrative databases, IPTW and IPTW-Cox models estimate incidence and hazard ratios after excluding prior bladder or colorectal cancer.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/secondary-bladder-and-colorectal-cancer-after-treatments-for-prostate-cancer-a-population-based-study/337515/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/secondary-bladder-and-colorectal-cancer-after-treatments-for-prostate-cancer-a-population-based-study/337515.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s primary objective?","Question",{"text":113,"@type":114},"To determine the association between prostate cancer treatments (RP, EBRT, BT, and ADT) and the risk of secondary bladder and colorectal cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was confounding controlled in the analysis?",{"text":118,"@type":114},"The study used inverse probability of treatment weighting (IPTW) based on a propensity score, followed by IPTW-Cox proportional hazards models.",{"name":120,"@type":111,"acceptedAnswer":121},"Which treatments showed significant associations with secondary bladder cancer?",{"text":122,"@type":114},"Secondary bladder cancer was significantly associated with EBRT and EBRT+ADT, and also with ADT alone, compared with RP.",{"name":124,"@type":111,"acceptedAnswer":125},"Which treatments were linked to secondary colorectal cancer?",{"text":126,"@type":114},"Secondary colorectal cancer was significantly associated with EBRT and BT, and ADT alone was also associated with risk.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},337515,1790147661,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":41,"preview_page_count":19,"preview_urls":150},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","DOI: 10. 1002/cam4 .6922  \nRESEAR CH ARTICLE  \nSecondary bladder and colorectal cancer after treatments for prostate cancer: A population based study  \nPatricia Grisel Quintana Bárcena1,2  | Armen Garo Aprikian1,3 | Alice Dragomir1,2,4   \n1Urology, Department of Surgery, McGill University, Montreal, Quebec, Canada  \n2Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada  \n3McGill University Health Centre, Montreal, Quebec, Canada 4Faculty of pharmacy, University of Montreal, Montreal, Quebec, Canada  \nCorrespondence  \nAlice Dragomir, Faculty of pharmacy, University of Montreal, C.P. 6128, succursale Centre-ville, Montréal, Québec H3C 3J7, Canada.  \nEmail: [alice.dragomir@umontreal.ca](alice.dragomir@umontreal.ca)  \nFunding information  \nFonds de Recherche du Québec-Santé; Réseau de cancérologie Rossy  \nAbstract  \nBackground: Prostate cancer (PCa) patients receiving radiotherapy may be predisposed to secondary malignancies. This study aimed to determine the association between PCa treatments, including radical prostatectomy (RP), external beam radiation therapy (EBRT), brachytherapy (BT) and androgen deprivation therapy (ADT); and secondary bladder and colorectal cancer.  \nMethods: A cohort study was constructed using Quebec administrative databases (Med-Echo and RAMQ) . Included men were diagnosed and treated for PCa between 2000 and 2016. Patients with bladder or colorectal cancer prior to PCa were excluded. Follow-up ended at the earliest of the following: incidence of bladder or colorectal cancer, death, or December 31, 2016. EBRT, BT, EBRT+ADT, RP+ADT or ADT only were compared individually to RP. The incidence of secondary bladder and colorectal cancer were computed. Inverse probability of treatment weighting (IPTW) based on a propensity score was used to control for potential confounding. IPTW-Cox proportional hazards models were used. Results: A significant association was found between secondary bladder cancer and EBRT (HR: 1.84, 95%CI: 1.60;2 . 13), and also EBRT+ADT (HR: 2.08, 95%CI: 1.67;2.56), but not with BT (HR: 1.36, 95%CI: 0.68;2.74) . Secondary colorectal cancer was significantly associated to either EBRT (HR: 1.36, 95%CI: 1.21;1.53); or BT (HR: 2.46, 95%CI: 1.71;3 . 54) . The association between ADT alone and both secondary cancers was also significant (HR: 1.98, 95%CI: 1.69;2.31 and HR: 1.69, 95%CI: 1.49;1.92, respectively) .  \nConclusions: Compared to PCa patients undergoing RP, the secondary bladder cancer was associated with EBRT, ADT, alone or in combination. The secondary colorectal cancer was also associated with receiving either EBRT, BT or ADT.  \nKEYWORDS  \nandrogen deprivation therapy, bladder cancer, brachytherapy, colorectal cancer, external beam radiation therapy, prostate cancer, secondary malignancies  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e6922 .  \n[https://doi.org/10.1002/cam4.6922](https://doi.org/10.1002/cam4.6922)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 12  \n1 | INTRODUCTION  \nProstate cancer (PCa) is the most common type of cancer in Canadian men, followed by colorectal, lung, and bladder; and the third deadliest cancer (9 .6% of cancer-related deaths) .1 According to the Canadian Cancer Society, 1 in 8 men will receive a PCa diagnosis during their lifetime and 1 in 29 will die from the disease.2  \nInitial treatments for PCa include radical prostatectomy (RP), radiotherapy (RT), or androgen deprivation therapy (ADT) .3 Common side effects of RP and RT include urinary and erectile dysfunction. RT is also associated with quality-of life-detriments affecting adjacent organs (i.e., bladder and rectum) .4,5 Common adverse effects include pelvic pain, lower urin","cbCaiv403rdClxGk","https://ap.wps.com/l/cbCaiv403rdClxGk","pdf",766896,12,"English","# Introduction\n## Prostate cancer treatments and baseline risks\n## Radiotherapy-related adverse effects and secondary cancer evidence\n## Androgen deprivation therapy and colorectal risk rationale","[{\"question\":\"What was the study’s primary objective?\",\"answer\":\"To determine the association between prostate cancer treatments (RP, EBRT, BT, and ADT) and the risk of secondary bladder and colorectal cancer.\"},{\"question\":\"How was confounding controlled in the analysis?\",\"answer\":\"The study used inverse probability of treatment weighting (IPTW) based on a propensity score, followed by IPTW-Cox proportional hazards models.\"},{\"question\":\"Which treatments showed significant associations with secondary bladder cancer?\",\"answer\":\"Secondary bladder cancer was significantly associated with EBRT and EBRT+ADT, and also with ADT alone, compared with RP.\"},{\"question\":\"Which treatments were linked to secondary colorectal cancer?\",\"answer\":\"Secondary colorectal cancer was significantly associated with EBRT and BT, and ADT alone was also associated with risk.\"}]","Secondary bladder and colorectal cancer after treatments for prostate cancer - A population based study | PDF",1790019387,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac40882cf2680b94eba973bd219c0882.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12150410e23c186d0cad68d79b3b4551.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00363fa99a045bea7e606933e97c4361.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85a5b7ea98268dd70edf85a8313a3e48.webp",980,1287]